南美洲和中美洲脑癌诊断市场预测至 2028 年 - COVID-19 影响和按诊断类型(影像测试、腰椎穿刺、活检、分子测试等)进行的区域分析;癌症类型(听神经瘤、星形细胞瘤、颅咽管瘤、神经节神经瘤、多形性胶质母细胞瘤、脑膜瘤、室管膜瘤等);最终用户(医院、专科诊所、门诊手术中心等)

TIPRE00025906 | Pages: 145 | Medical Device | Nov 2021 | Type: Regional | Status: Published

市场介绍

脑癌是由于大脑中导致肿瘤的细胞在细胞外生长而引起的。肿瘤包括原发性脑肿瘤和继发性脑肿瘤。原发性脑肿瘤在大脑中形成,不会扩散到身体其他部位,而继发性肿瘤,也称为转移瘤,是那些始于身体其他部位的癌症。脑肿瘤分为40种主要类型,进一步分为两大类,包括良性(即生长缓慢且不易扩散)和恶性(即癌变且更容易扩散)。

< p>因此,脑癌患病率的增加预计将在未来几年对脑癌诊断产生巨大需求,预计这将进一步推动脑癌诊断市场的发展。

COVID? 19日大流行对南美洲和中美洲已经负担过重且资金不足的公共医疗系统来说是一次严峻的考验。它遭受着严重的不平等。由于大量人口生活在贫困之中,南美洲和中美洲由于过度拥挤、卫生条件有限、粮食不安全和不可预测的环境条件而持续面临广泛的健康问题。资金不足的公立医院是该地区唯一的医疗服务来源。由于新冠肺炎 (COVID-1),巴西正处于危急境地。资源缺乏给该地区带来了更多挑战,阻碍了脑癌诊断市场的增长。所有这些因素都将限制诊断产品和服务的分销和采用,从而限制市场增长。然而,随着疫苗接种继续在这些国家进行,该地区的各个市场参与者将再次开始关注脑癌诊断的开发并增加产品的分销。因此,大流行对脑癌诊断市场的影响将减弱。

 

市场概况和动态

南美洲和中美洲的脑癌诊断市场预计将从2021年的6970万美元增长到2028年的1.758亿美元;预计 2021 年至 2028 年复合年增长率为 14.1%。“原发性脑肿瘤”一词是指始于大脑的肿瘤。脑部和神经系统癌症是男性和女性第十大死因。在人的一生中,患这种肿瘤的几率不到 1%。大多数原发性中枢神经系统 (CNS) 恶性肿瘤是脑肿瘤,占所有病例的 85% 至 90%。脑肿瘤可能致命,严重影响生活质量,并最终改变患者及其家人的生活。此外,肿瘤的早期发现通常可以提供更多的治疗选择。先进的成像技术可以精确定位脑肿瘤的位置。诊断工具包括磁共振成像 (MRI) 和计算机断层扫描(CT 或 CAT 扫描)。术中 MRI 还可用于指导手术期间的组织活检和肿瘤切除。磁共振波谱(MRS)用于检查肿瘤的化学特征。因此,脑癌患病率的增加迫切需要脑癌诊断工具。      

 

主要细分市场

从诊断类型来看,影像测试细分市场在2020年南美洲和中美洲脑癌诊断市场中占据最大份额。 从癌症类型来看,多形性胶质母细胞瘤细分市场在南美洲和中美洲脑癌诊断市场中占据最大份额2020年癌症诊断市场。就最终用户而言,医院细分市场在2020年南美洲和中美洲脑癌诊断市场中占据最大份额。

 

主要来源和上市公司

准备时参考的一些主要一手和二手来源这份关于南美洲和中美洲脑癌诊断市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd. 和 Neusoft Medical Systems。

 

原因购买报告

  • 了解南美洲和中美洲脑癌诊断市场格局并确定最有可能的细分市场保证丰厚的回报
  • 了解南美洲和中美洲脑癌诊断市场不断变化的竞争格局,保持领先地位
  • 有效规划南美洲的并购和合作交易通过识别最有前景的可能销售的细分市场,帮助中南美洲和中美洲脑癌诊断市场通过对南美洲和中美洲脑癌诊断市场各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
  • 获取南美洲和中美洲地区2021-2028年各细分市场的市场收入预测

 

南美洲和中美洲脑癌诊断市场细分      

 

按诊断类型

  • 影像学检查
    • MRI
    • CT扫描
    • PET
  • 活检
  • 分子检测
  • 腰椎穿刺
  • 其他

 

按癌症类型

< ul>
  • 多形性胶质母细胞瘤
  • 星形细胞瘤
  • 室管膜瘤
  • 其他
  •  

    最终用户

    • 医院
    • 专科诊所
    • 门诊手术中心
    • 其他

     

    按国家/地区

    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

     

    提及的公司

    1. Thermo Fisher Scientific Inc.
    2. Siemens Healthineers A
    3. GE Healthcare
    4. Biocept, Inc.
    5. Koninklijke Philips NV
    6. 佳能医疗系统
    7. 日立株式会社
    8. 东软医疗系统

     

     

    TABLE OF CONTENTS

    1.           Introduction

    1.1          Scope of the Study

    1.2          The Insight Partners Research Report Guidance

    1.3          Market Segmentation

    1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

    1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

    1.3.3          Brain Cancer Diagnostics Market – By End User

    1.3.4          South and Central America Brain Cancer Diagnostics Market – By Country

    2.           South and Central America Brain Cancer Diagnostics Market – Key Takeaways

    3.           Research Methodology

    3.1          Coverage

    3.2          Secondary Research

    3.3          Primary Research

    4.           South and Central America Brain Cancer Diagnostics Market – Market Landscape

    4.1          Overview

    4.2          PEST Analysis

    4.2.1          Brain Cancer Diagnostics Market- South and Central America PEST Analysis

    4.3          Expert Opinion

    5.           South and Central America Brain Cancer Diagnostics Market - Key Market Dynamics

    5.1          Market Drivers

    5.1.1          Increase in Prevalence of Brain Cancer

    5.1.2          Rise in Number of Cigarette Smokers

    5.2          Market Restraints

    5.2.1          High Cost of Diagnosis

    5.3          Future Trends

    5.3.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

    5.4          Impact Analysis

    6.           Brain Cancer Diagnostics Market – South and Central America Analysis

    6.1          South and Central America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

    7.           South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

    7.1          Overview

    7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

    7.3          Imaging Tests

    7.3.1          Overview

    7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.3          MRI

    7.3.3.1             Overview

    7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.4          CT Scan

    7.3.4.1             Overview

    7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.5          Positron emission tomography (PET)

    7.3.5.1             Overview

    7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.4          Lumbar Puncture

    7.4.1          Overview

    7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.5          Biopsy

    7.5.1          Overview

    7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.6          Molecular Testing

    7.6.1          Overview

    7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.7          Others

    7.7.1          Overview

    7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.           South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

    8.1          Overview

    8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

    8.3          Astrocytomas

    8.3.1          Overview

    8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.4          Glioblastoma Multiforme

    8.4.1          Overview

    8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.5          Ependymomas

    8.5.1          Overview

    8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.6          Others

    8.6.1          Overview

    8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.           Brain Cancer Diagnostics Market Analysis – By End user

    9.1          Overview

    9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

    9.3          Hospitals

    9.3.1          Overview

    9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.4          Specialty Clinics

    9.4.1          Overview

    9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.5          Ambulatory Surgical Centers

    9.5.1          Overview

    9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.6          Others

    9.6.1          Overview

    9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

    10.1        South and Central America: Brain Cancer Diagnostics Market

    10.1.1        Overview

    10.1.2        South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

    10.1.2.1          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.2          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.2.1           Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

    10.1.2.2.1.1     Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    10.1.2.2.2           Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    10.1.2.2.3           Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    10.1.2.3          Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.3.1           Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.3.2           Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

    10.1.2.3.2.1     Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    10.1.2.3.3           Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    10.1.2.3.4           Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    10.1.2.4          Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.4.1           Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    10.1.2.4.2           Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

    10.1.2.4.3           Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    10.1.2.4.4           Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

    10.1.2.4.5           Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    11.        Impact Of COVID-19 Pandemic on South and Central America Brain Cancer Diagnostics Market

    11.1        South and Central America: Impact Assessment of COVID-19 Pandemic

    12.        Industry Landscape

    12.1        Overview

    12.2        Growth Strategies Done by the Companies in the Market, (%)

    12.1        Organic Developments

    12.1.1        Overview

    12.2        Inorganic Developments

    12.2.1        Overview

    13.        Company Profiles

    13.1        THERMO FISHER SCIENTIFIC INC.

    13.1.1        Key Facts

    13.1.2        Business Description

    13.1.3        Products and Services

    13.1.4        Financial Overview

    13.1.5        SWOT Analysis

    13.1.6        Key Developments

    13.2        Siemens Healthineers AG

    13.2.1        Key Facts

    13.2.2        Business Description

    13.2.3        Products and Services

    13.2.4        Financial Overview

    13.2.5        SWOT Analysis

    13.2.6        Key Developments

    13.3        GE Healthcare

    13.3.1        Key Facts

    13.3.2        Business Description

    13.3.3        Products and Services

    13.3.4        Financial Overview

    13.3.5        SWOT Analysis

    13.3.6        Key Developments

    13.4        Biocept, Inc.

    13.4.1        Key Facts

    13.4.2        Business Description

    13.4.3        Products and Services

    13.4.4        Financial Overview

    13.4.5        SWOT Analysis

    13.4.6        Key Developments

    13.5        Koninklijke Philips N.V.

    13.5.1        Key Facts

    13.5.2        Business Description

    13.5.3        Products and Services

    13.5.4        Financial Overview

    13.5.5        SWOT Analysis

    13.5.6        Key Developments

    13.6        Canon Medical Systems

    13.6.1        Key Facts

    13.6.2        Business Description

    13.6.3        Products and Services

    13.6.4        Financial Overview

    13.6.5        SWOT Analysis

    13.6.6        Key Developments

    13.7        Hitachi, Ltd.

    13.7.1        Key Facts

    13.7.2        Business Description

    13.7.3        Products and Services

    13.7.4        Financial Overview

    13.7.5        SWOT Analysis

    13.7.6        Key Developments

    13.8        Neusoft Medical Systems

    13.8.1        Key Facts

    13.8.2        Business Description

    13.8.3        Products and Services

    13.8.4        Financial Overview

    13.8.5        SWOT Analysis

    13.8.6        Key Developments

    14.        Appendix

    14.1        About the Insight Partners

    14.2        Glossary of Terms

     


    LIST OF TABLES

    Table 1.              Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 2.              Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 3.              Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 4.              Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 5.              Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

    Table 6.              Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 7.              Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 8.              Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 9.              Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028  (USD Million)

    Table 10.            Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

    Table 11.            Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

    Table 12.            Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 13.            Organic Developments in the Brain Cancer Diagnostics Market

    Table 14.            Inorganic Developments in the Brain Cancer Diagnostics Market

    Table 15.            Glossary of Terms, Brain Cancer Diagnostics Market

     


    LIST OF FIGURES

    Figure 1.            Brain Cancer Diagnostics Market Segmentation

    Figure 2.            South and Central America Brain Cancer Diagnostics Market Overview

    Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

    Figure 4.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

    Figure 5.            Brain Cancer Diagnostics Market - South and Central America PEST Analysis

    Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

    Figure 7.            South and Central America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

    Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

    Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

    Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

    Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27.          South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

    Figure 28.          South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 29.          Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    Figure 30.          Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    Figure 31.          Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)

    Figure 32.          Impact of COVID-19 Pandemic in South and Central American Country Markets

    Figure 33.          Growth Strategies Done by the Companies in the Market, (%)

    1. Thermo Fisher Scientific Inc.
    2. Siemens Healthineers A
    3. GE Healthcare
    4. Biocept, Inc.
    5. Koninklijke Philips N.V
    6. Canon Medical Systems
    7. Hitachi, Ltd.
    8. Neusoft Medical Systems
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America brain cancer diagnostics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000